WIC
AGN

Wilkins Investment Counsel’s Allergan plc AGN Stock Holding History

Wilkins Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-900
Closed -$219K – 75
2017
Q2 		$219K Hold
900
– – 0.07% 76
2017
Q1 		$215K Sell
900
-215
-19% -$50.1K 0.07% 75
2016
Q4 		$234K Hold
1,115
– – 0.07% 76
2016
Q3 		$257K Hold
1,115
– – 0.09% 71
2016
Q2 		$258K Buy
1,115
+50
+5% +$11.5K 0.09% 75
2016
Q1 		$285K Sell
1,065
-50
-4% -$14.3K 0.1% 72
2015
Q4 		$348K Hold
1,115
– – 0.13% 70
2015
Q3 		$303K Sell
1,115
-50
-4% -$15.4K 0.12% 74
2015
Q2 		$354K Hold
1,165
– – 0.13% 71
2015
Q1 		$347K Sell
1,165
-57
-5% -$16.3K 0.12% 72
2014
Q4 		$315K Hold
1,222
– – 0.11% 74
2014
Q3 		$295K Buy
+1,222
New +$273K 0.11% 74

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Wilkins Investment Counsel's AGN Position: Q3 2017 in Review

Wilkins Investment Counsel sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 900 shares — an estimated $219K sold.

Wilkins Investment Counsel first reported a position in AGN in Q3 2014 and held it in 12 quarters. The position peaked at $354K in Q2 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Wilkins Investment Counsel reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Wilkins Investment Counsel sold 900 Allergan plc shares in Q3 2017, an estimated $219K.
  • Wilkins Investment Counsel first reported a position in Allergan plc in Q3 2014 and held it in 12 quarters.
  • Wilkins Investment Counsel's Allergan plc position peaked at $354K in Q2 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Wilkins Investment Counsel's 13F filing for Q3 2017, filed 13 Nov 2017.